Menu
Back to User profile » Dr Arif Khan
Papers published by Dr Arif Khan:
Neuroprotective Effects of Melatonin and Celecoxib against Ethanol-Induced Neurodegeneration: A Computational and Pharmacological Approach [Corrigendum]
Al Kury LT, Zeb A, Abidin ZU, Irshad N, Malik I, Alvi AM, Khalil AAK, Ahmad S, Faheem M, Khan AU, Shah FA, Li S
Drug Design, Development and Therapy 2023, 17:2931-2932
Published Date: 22 September 2023
Natural Dietary Supplement, Carvacrol, Alleviates LPS-Induced Oxidative Stress, Neurodegeneration, and Depressive-Like Behaviors via the Nrf2/HO-1 Pathway [Retraction]
Naeem K, Tariq Al Kury L, Nasar F, Alattar A, Alshaman R, Shah FA, Khan AU, Li S
Journal of Inflammation Research 2022, 15:6071-6072
Published Date: 7 November 2022
Bicarbonate Therapy in Renally Compromised Critically Ill Patients with Metabolic Acidosis: Study of Clinical Outcomes and Mortality Rate
Rafique Z, Tariq MH, Khan A, Farrukh MJ, Khan N, Burki AM, Mehmood K
International Journal of General Medicine 2021, 14:2817-2826
Published Date: 24 June 2021
RETRACTED ARTICLE: Natural Dietary Supplement, Carvacrol, Alleviates LPS-Induced Oxidative Stress, Neurodegeneration, and Depressive-Like Behaviors via the Nrf2/HO-1 Pathway
Naeem K, Tariq Al Kury L, Nasar F, Alattar A, Alshaman R, Shah FA, Khan AU, Li S
Journal of Inflammation Research 2021, 14:1313-1329
Published Date: 8 April 2021
Thiazolidine Derivatives Attenuate Carrageenan-Induced Inflammatory Pain in Mice
Malik Z, Abbas M, Al Kury LT, Shah FA, Alam M, Khan AU, Nadeem H, Alghamdi S, Sahibzada MUK, Li S
Drug Design, Development and Therapy 2021, 15:369-384
Published Date: 4 February 2021
Computational and Pharmacological Investigation of (E)-2-(4-Methoxybenzylidene)Cyclopentanone for Therapeutic Potential in Neurological Disorders
Farooq S, Khan A, Iqbal MS
Drug Design, Development and Therapy 2020, 14:3601-3614
Published Date: 7 September 2020
Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach
Al Kury LT, Zeb A, Abidin ZU, Irshad N, Malik I, Alvi AM, Khalil AAK, Ahmad S, Faheem M, Khan AU, Shah FA, Li S
Drug Design, Development and Therapy 2019, 13:2715-2727
Published Date: 2 August 2019
Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches
Aqeel MT, ur-Rahman N, Khan A, Ashraf Z, Latif M, Rafique H, Rasheed U
Drug Design, Development and Therapy 2018, 12:2443-2453
Published Date: 9 August 2018